XWELL reports 13% revenue growth in 2024, plans expansion into wellness and beauty sector.

From GlobeNewswire: 2025-04-15 17:15:00

XWELL, Inc. reported a 13% revenue growth in 2024, with operating expenses reduced by 19%. The company extended its Traveler-based Genomic Surveillance Program with the CDC and announced plans to acquire medical spas. XWELL aims to unify its wellness offerings under the XWELL brand and expand into the high-growth wellness and beauty sector. The company also announced the opening of a new Naples Wax Center in Florida and plans to open 6 additional locations in 2025. XWELL is actively broadening its retail product portfolio to cater to the evolving needs of wellness-conscious consumers.

In 2024, XWELL’s total revenue was $33.9 million, with a net loss of approximately $16.9 million. The company’s revenue primarily came from XpresSpa, Treat, XpresTest, and Naples Wax Center. XWELL significantly reduced operating expenses and continued to focus on overall profitability. The company closed a $4 million private placement offering in January 2025. XWELL is a leading global wellness holding company operating brands such as XWELL, XpresSpa, Treat, Naples Wax Center, XpresCheck, and HyperPointe.



Read more at GlobeNewswire: XWELL Reports Fiscal Year 2024 Results